PMID: 46388Feb 1, 1975

Advanced diffuse histiocytic lymphoma, a potentially curable disease

Lancet
V T DeVitaR C Young

Abstract

Twenty-seven patients with advanced diffuse histiocytic lymphoma (reticulum-cell sarcoma) were treated with combination chemotherapy utilising nitrogen mustard (or cyclophosphamide), procarbazine, vincristine, and prednisone. Elven (41%) achieved a complete remission and only one of these has had a recurrence of tumour. The remaining ten complete responders were free of all evidence of tumour when last seen 26-105 months from the end of treatment. In contrast, all non-responders or partial responders have died. An interpretation of published survival data suggests that this virulent disease evolves quickly and is usally rapidly fatal if treatment is unsuccessful. Survival free of disease beyond 2 years from the end of treatment may be considered tantamount to cure. This definition of cure, previously applied only to patients treated with radiotherapy, seems applicable to patients who acheive complete remissions with modern drug treatment.

References

Jan 1, 1986·Journal of Cancer Research and Clinical Oncology·J P Dutcher, P H Wiernik
Jan 1, 1986·Gastrointestinal Radiology·S A TeefeyP F Sheedy
Aug 21, 2009·Annals of Hematology·Michael A FridrikRichard Greil
Apr 4, 2009·Targeted Oncology·James O Armitage
Oct 23, 2012·International Journal of Hematology·Mark RoschewskiWyndham H Wilson
Sep 1, 1989·Disease-a-month : DM·E R Gaynor, R I Fisher
Dec 1, 1981·Journal of Steroid Biochemistry·C D BloomfieldA Munck
Jan 1, 1979·Pharmacology & Therapeutics·B J Lewis, V T DeVita
Oct 1, 1991·Pharmacology & Therapeutics·E K Rowinsky, R C Donehower
Jan 1, 1995·International Journal of Radiation Oncology, Biology, Physics·L M FullerJ L Palmer
Mar 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J W DenhamG V Hudson
Jun 8, 2001·International Journal of Radiation Oncology, Biology, Physics·R B WilderJ D Cox
Jul 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D A CameronW D Thompson
Jun 23, 2000·Critical Reviews in Oncology/hematology·B CoudercD Schlaifer
Jul 2, 2003·Journal of the American College of Surgeons·L G KoniarisRabih Salloum
Mar 7, 2000·Journal of the American College of Surgeons·L G KoniarisJ L Cameron
Nov 13, 2013·Nature Reviews. Clinical Oncology·Mark RoschewskiWyndham H Wilson
May 1, 2006·Clinics in Colon and Rectal Surgery·Frank J Quayle, Jennifer K Lowney
Jul 17, 1975·The New England Journal of Medicine·E Frei
Sep 1, 1977·The New England Journal of Medicine·S B Murphy, A M Mauer
Dec 21, 1978·The New England Journal of Medicine·J A StrauchenC W Berard
Apr 8, 1993·The New England Journal of Medicine·J O Armitage
May 2, 2003·The New England Journal of Medicine·Louis M Staudt
Jan 1, 1989·Annals of Surgery·T H WebbJ L Cameron
Aug 1, 1978·British Journal of Haematology·G P Canellos, T A Lister
Jan 1, 1987·Postgraduate Medical Journal·D CunninghamM Soukop
Dec 1, 1980·The Journal of Clinical Investigation·S E ShackneyR J Lukes
Apr 1, 1984·The Journal of Clinical Investigation·S E ShackneyJ W Parker
Mar 25, 2008·Therapeutics and Clinical Risk Management·Jean-Pierre ArmandLauren Abrey
Oct 1, 1979·Clinics in Haematology·T J ErvinJ S Greenberger
Feb 7, 2012·Mayo Clinic Proceedings·James O Armitage
Apr 1, 1981·Pathology, Research and Practice·P MeusersG Brittinger
Feb 25, 2011·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·James O Armitage
Jan 1, 1983·International Journal of Radiation Oncology, Biology, Physics·M K GospodarowiczT Chua
Mar 13, 2016·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Han-I WangRussell Patmore
Oct 1, 2010·British Journal of Haematology·Julie M VoseJames O Armitage
Sep 24, 2011·The Lancet Oncology·Fernando Cabanillas
Jan 1, 1986·Cancer Investigation·T D Shenkenberg, C A Coltman

Citations

Feb 1, 1966·The Journal of Experimental Zoology·R Rappaport
Jul 1, 1972·Cancer·S E JonesR F Dorfman
Sep 1, 1973·Cancer·S E JonesS A Rosenberg
Oct 1, 1970·Radiology·J Newall, M Friedman

Related Concepts

Procarbazine
Nitrogen Mustard Compounds
Antineoplastic Agents
Lymphoma, Non-Hodgkin
Cyclophosphamide
Remission, Spontaneous
Neoplasms
Vincristine
Tumor Lysis Syndrome
Recurrent Tumor

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.